# VIRAX BIOLABS GROUP LTD (VRAX)

> Institutional ownership reported to the SEC as of Q1 2026, from Form 13F filings. Source: https://holderbook.com/stocks/VRAX/

- Reporting holders: 4
- Reported value: $202.2K
- Shares held by institutions: 919,568 of 579,218 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [ARMISTICE CAPITAL, LLC](https://holderbook.com/funds/1601086-armistice-capital-llc/) | $193.2K | 878,803 | 0.0% | 1 |
| [Jump Financial, LLC](https://holderbook.com/funds/1831577-jump-financial-llc/) | $9.0K | 40,724 | 0.0% | 1 |
| [OSAIC HOLDINGS, INC.](https://holderbook.com/funds/1677044-osaic-holdings-inc/) | $4 | 20 | 0.0% | 2 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $4 | 21 | 0.0% | 3 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2026 | 4 | $202.2K |
| Q4 2025 | 6 | $12.1K |
| Q3 2025 | 5 | $57.1K |
| Q2 2025 | 2 | $28.6K |
| Q1 2025 | 4 | $71.5K |
| Q4 2024 | 7 | $141.4K |
| Q3 2024 | 5 | $423.6K |
| Q2 2024 | 7 | $81.8K |
| Q1 2024 | 3 | $12.5K |
| Q4 2023 | 4 | $195.4K |
| Q3 2023 | 4 | $10.9K |
| Q2 2023 | 4 | $22.8K |